Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights

On Tuesday, Novartis AG NVS reported third-quarter sales of $12.823 billion, up 9% (+10% on constant currency), beating the consensus of $12.76 billion. Guidance: Novartis also raised its 2024 full-year guidance again this year. In a statement, Novartis said it expects full-year core operating income to grow by a "high teens" percentage, compared with previous guidance of a "mid-to-high teens" percentage. Novartis forecasts full-year sales growth in the low double digits, having previously guided for high-s ...